Structure−Activity Relationship Studies of Chalcone Leading to 3-Hydroxy-4,3′,4′,5′-tetramethoxychalcone and Its Analogues as Potent Nuclear Factor κB Inhibitors and Their Anticancer Activities

doi:10.1021/JM901278Z

Paper

Structure−Activity Relationship Studies of Chalcone Leading to 3-Hydroxy-4,3′,4′,5′-tetramethoxychalcone and Its Analogues as Potent Nuclear Factor κB Inhibitors and Their Anticancer Activities

Published Nov 2, 2009 · B. Srinivasan, T. E. Johnson, Rahul R. Lad

Journal of Medicinal Chemistry

Q1 SJR score

168

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Chalcone is a privileged structure, demonstrating promising anti-inflammatory and anticancer activities. One potential mechanism is to suppress nuclear factor kappa B (NF-κB) activation. The structures of chalcone-based NF-κB inhibitors vary significantly that there is minimum information about their structure−activity relationships (SAR). This study aims to establish SAR of chalcone-based compounds to NF-κB inhibition, to explore the feasibility of developing simple chalcone-based potent NF-κB inhibitors, and to evaluate their anticancer activities. Three series of chalcones were synthesized in one to three steps with the key step being aldol condensation. These candidates demonstrated a wide range of NF-κB inhibitory activities, some of low micromolar potency, establishing that structural complexity is not required for NF-κB inhibition. Lead compounds also demonstrate potent cytotoxicity against lung cancer cells. Their cytotoxicities correlate moderately well with their NF-κB inhibitory activities, sug...

In Vitro Study

Highly Cited

Study Snapshot

Chalcone-based compounds show potential as potent NF-B inhibitors and show potent cytotoxicity against lung cancer cells, suggesting their potential as anti-inflammatory and cancer treatments.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Paper

Structure−Activity Relationship Studies of Chalcone Leading to 3-Hydroxy-4,3′,4′,5′-tetramethoxychalcone and Its Analogues as Potent Nuclear Factor κB Inhibitors and Their Anticancer Activities

References

Citations

Discovery of novel dual tubulin and MMPs inhibitors for the treatment of lung cancer and overcoming drug resistance.

15j, a dual tubulin and MMP inhibitor, shows significant potential for lung cancer therapy by inhibiting cell proliferation, migration, and invasion while promoting mitochondrial dysfunction and DNA damage.

Synthesis and Antiproliferative Effect of New Alkyne-Tethered Vindoline Hybrids Containing Pharmacophoric Fragments

A trimethoxyphenyl-containing chalcone-vindoline hybrid (36) shows promising antiproliferative activity on A2780 ovarian cancer cells with a marked therapeutic window.

Benzylidene-isophorone hybrids with strong anticancer activity.

Benzylidene-isophorone hybrids show strong anticancer activity, with the most potent effects observed in the parent compound with ortho, ortho directing -Cl (1).

Design, Synthesis and Apoptotic Activity of Substituted Chalcones Tethered 1,3,5-Triazine Hybrids: An Insights from Molecular Docking, Molecular Dynamics Simulations, DFT, ADME, and DAPI Analyses

Substituted chalcone tethered 1,3,5-triazine hybrids show promising anticancer activity against MCF7, A549, PC3, and Colo-205 human cancer cell lines, with two compounds showing the most promising activities.

Multitargeted Molecular Docking and Dynamics Simulation of Thymol-Based Chalcones against Cancer Protein Markers: Synthesis, Characterization, and Computational Study

Compounds 4d and 4b, synthesized from natural thymol, show promising potential as targeted EGFR cancer treatments due to their favorable physicochemical properties and ADMET profiles.

Novel NF-κB Inhibitor-Conjugated Pt(IV) Prodrug to Enable Cancer Therapy through ROS/ER Stress and Mitochondrial Dysfunction and Overcome Multidrug Resistance.

A novel NF-B inhibitor-conjugated Pt(IV) prodrug shows high efficiency and low toxicity in cancer therapy, overcoming multidrug resistance and enhancing cisplatin's effectiveness.

Structure-based discovery of potent myosin inhibitors to guide antiparasite drug development.

Shikonin and 1,4-naphthoquinone show potential as alternative compounds to control Gyrodactylus infections in aquaculture, offering potential for future anthelmintic control through combinatorial or replacement strategies.

Recent Trends in the Synthesis and Bioactivity of Coumarin, Coumarin–Chalcone, and Coumarin–Triazole Molecular Hybrids

Recent trends in synthesis of coumarins, coumarin-chalcone, and coumarin-triazole molecular hybrids show promising bioactivity results, with potential applications in antioxidative, antimicrobial, anticancer, antidiabetic, and anti-cholinesterase fields.